1. Home
  2. REVB vs DGLY Comparison

REVB vs DGLY Comparison

Compare REVB & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • DGLY
  • Stock Information
  • Founded
  • REVB 2020
  • DGLY 2004
  • Country
  • REVB United States
  • DGLY United States
  • Employees
  • REVB N/A
  • DGLY N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • REVB Health Care
  • DGLY Technology
  • Exchange
  • REVB Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • REVB 3.8M
  • DGLY 3.9M
  • IPO Year
  • REVB N/A
  • DGLY N/A
  • Fundamental
  • Price
  • REVB $2.88
  • DGLY $2.04
  • Analyst Decision
  • REVB
  • DGLY
  • Analyst Count
  • REVB 0
  • DGLY 0
  • Target Price
  • REVB N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • REVB 269.2K
  • DGLY 87.5K
  • Earning Date
  • REVB 08-08-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • REVB N/A
  • DGLY N/A
  • EPS Growth
  • REVB N/A
  • DGLY N/A
  • EPS
  • REVB N/A
  • DGLY N/A
  • Revenue
  • REVB N/A
  • DGLY $18,596,715.00
  • Revenue This Year
  • REVB N/A
  • DGLY N/A
  • Revenue Next Year
  • REVB N/A
  • DGLY N/A
  • P/E Ratio
  • REVB N/A
  • DGLY N/A
  • Revenue Growth
  • REVB N/A
  • DGLY N/A
  • 52 Week Low
  • REVB $2.11
  • DGLY $1.91
  • 52 Week High
  • REVB $168.00
  • DGLY $217.00
  • Technical
  • Relative Strength Index (RSI)
  • REVB 44.79
  • DGLY 26.58
  • Support Level
  • REVB $2.97
  • DGLY $1.91
  • Resistance Level
  • REVB $3.18
  • DGLY $2.11
  • Average True Range (ATR)
  • REVB 0.23
  • DGLY 0.12
  • MACD
  • REVB 0.13
  • DGLY 0.49
  • Stochastic Oscillator
  • REVB 60.37
  • DGLY 31.71

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: